BHCM
XYL icon

Brevan Howard Capital Management’s Xylem XYL Stock Holding History

Brevan Howard Capital Management’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,153
Closed -$974K – 2637
2026
Q1 		$974K Sell
8,153
-6,111
-43% -$801K 0.01% 912
2025
Q4 		$1.94M Buy
14,264
+7,170
+101% +$1.03M 0.02% 490
2025
Q3 		$1.05M Buy
7,094
+3,846
+118% +$533K ﹤0.01% 873
2025
Q2 		$420K Buy
+3,248
New +$393K ﹤0.01% 1424
2024
Q3 		– Sell
-8,969
Closed -$1.22M – 1485
2024
Q2 		$1.22M Buy
8,969
+7,339
+450% +$998K 0.01% 323
2024
Q1 		$211K Buy
+1,630
New +$197K ﹤0.01% 783

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Brevan Howard Capital Management's XYL Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Xylem (XYL) in Q2 2026, closing a stake of 8,153 shares — an estimated $974K sold.

Brevan Howard Capital Management first reported a position in XYL in Q1 2024 and held it in 6 quarters. The position peaked at $1.94M in Q4 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 8,153 Xylem shares in Q2 2026, an estimated $974K.
  • Brevan Howard Capital Management first reported a position in Xylem in Q1 2024 and held it in 6 quarters.
  • Brevan Howard Capital Management's Xylem position peaked at $1.94M in Q4 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.